What All Hematologic Oncologists Should Know About Diagnosis, Staging of DLBCL

By The Fellow on Call - Last Updated: October 2, 2023

In this episode of “The Fellow on Call,” hosts Ronak Mistry, DO; Vivek Patel, MD; and Dan Hausrath, MD, kick off a new series focusing on diffuse large B-cell lymphoma (DLBCL).

In the first episode of the series, they discuss how to evaluate a patient for DLBCL, the characteristic patterns of DLBCL on flow cytometry and the steps for diagnosing and staging DLBCL.

They also cover how to perform risk stratification in patients with DLBCL, covering cell-of-origin classification methods, gene expression profiling, algorithms, and more. Additionally, they highlight important cytogenetic features in DLBCL, how to interpret Ki-67 data, as well as Ann Arbor and Lugano staging.

This podcast originally appeared on thefellowoncall.com

Advertisement
Advertisement
Advertisement
Editorial Board